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Abstract 
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) emerged at the Pediatric Hospital of Misiones Province, north Argentina, 
in 2003 as a cause of community-acquired (CA) infections, mostly associated with skin and soft tissue infections (SSTIs). This study aimed 
to assess the microbiological, epidemiological, and clinical features of CA-MRSA SSTIs treated at the hospital. 
Methodology: From 2003 through 2006, a longitudinal study on CA-MRSA SSTIs was conducted. Clinical, bacteriological, and molecular 
data were collected and analyzed by multiple correspondences and cluster analysis (MCCA). 
Results: A total of 138 children were enrolled; 55.8% of the children required hospitalization. The main clinical presentation was abscesses 
(51%). Antibiotic therapy in the previous six months was registered in 41% of the patients, and 72% of the patients had relatives with similar 
symptoms. Resistance to non--lactam antibiotics was found in less than 12% of patients. All 44 isolates carried staphylococcal cassette 
chromosomemec (SCCmec) type IV, and 30/44 had Panton-Valentine leucocidin (PVL) coding genes. Six pulsed-field gel electrophoresis 
(PFGE) patterns were detected from 17 isolates. MCCA hierarchic classification resulted in four distinctive patient classes (new variable). No 
relationship could be observed regarding the PVL detection, as PVL (+) isolates were detected in all classes; the same lack of significance 
was observed concerning the distribution of resistance to non-β-lactam antibiotics. 
Conclusions: This study increases the understanding and knowledge about CA-MRSA skin and soft tissue infections in pediatric patients. 
Continuous efforts should be made to control this significant public health problem. 
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Introduction 
Methicillin-resistant Staphylococcus aureus 
(MRSA) has emerged as a cause of infection among 
otherwise healthy children and adults in the 
community. Skin and softtissue infections (SSTIs) are 
frequent, and children area population particularly 
affected [1,2]. 
Even if the majority of community-associated 
MRSA (CA-MRSA) isolates are susceptible to a 
number of non-β-lactam antimicrobial agents, 
resistance patterns change in different locations [3]. 
CA-MRSA strains harbour SCCmec type IV or V, 
differing from the classical hospital-acquired (HA) 
MRSA strains that carry SCCmec type I, II, or III. 
Additionally, several studies have described that 
Panton-Valentine leukocidin (PVL), together with 
SCCmec type IV or V and a specific genetic 
background, is a genetic marker for CA-MRSA [4]. 
The contribution of this toxin to the virulence of S. 
aureus has been highly discussed, although 
necrotizing skin and softtissue infections as well as 
necrotizing pneumonia have been shown to be 
epidemiologically associated with PVL-producing 
strains [5-7]. 
MRSA emerged at the Provincial Pediatric 
Hospital of Posadas in Misiones Province, Argentina 
(PPHM) in 2003 as a cause of community-acquired 
infections, even replacing methicillin-sensitive S. 
aureus (38% in 2003 to 58% in 2006) and was 
associated with SSTIs and invasive infections. This 
proportion was maintained to 2010 when we observed 
that a 60% of S. aureus isolated were MRSA (M. von 
Specht, unpublished results). 
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In this study we aimed to assess the 
microbiological, epidemiological, and clinical features 
of skin and soft tissue infections caused by CA-MRSA 
at PPHM. 
 
Methodology 
Setting 
The PPHM is a 120-bed tertiary care hospital and 
Reference Center for the region. This public hospital 
receives patients from other areas of Misiones as well 
as from northern Corrientes province (Argentina), 
southern Paraguay, and a few patients from southern 
Brazil. 
From January 2003 to December 2006, all 
consecutive single patient isolates (n = 138) identified 
as CA-MRSA that were recovered from patients 
between 1 month and 14 years of age diagnosed with 
SSTI were included. 
CA-MRSA infection was defined as culture-
confirmed MRSA infection in a patient without risk 
factors for hospital-acquired MRSA during the 
previous year, who acquired the infection outside 
hospital settings or within 72 hours of admission, 
according to CDC criteria [1, 8]. 
Clinical and socio-economic data from each 
patient were collected from medical records and from 
interviews with the patient guardians. Previous 
antibiotic therapy was defined as receiving antibiotics 
immediately prior treatment (patient treated at the time 
of sampling) or receiving antibiotics as pre-treatment 
for any other infection in the previous six months. The 
nutritional valuation was made according to Waterlow 
criteria [9]. 
The study was reviewed and approved by the 
Institutional Review Board; informed consent was not 
required. 
 
Microbiological studies 
Staphylococcal strains were isolated on 5% sheep's 
blood agar plates (Columbia agar base, Britania, 
Buenos Aires, Argentina) and identified on the basis 
of conventional diagnostic procedures. Antimicrobial 
susceptibility testing was performed by the disk 
diffusion method in accordance with the Clinical and 
Laboratory Standards Institute guidelines [10]. The 
antibiotics tested included oxacillin, cefoxitin, 
ciprofloxacin, gentamicin, rifampin, minociclin, 
trimethoprim/sulfamethoxazole, chloramphenicol, 
erythromycin, and clindamycin (Britania, Buenos 
Aires, Argentina). S. aureus ATCC 25923 and 43300 
were used as control strains. 
 
Molecular characterization 
Detection of the mecA and PVL coding genes was 
performed ona randomly selected group of 44 
available isolates, after extraction of genomic DNA as 
previously described [5,11-13]. SCCmec typing was 
performed by a multiplex PCR method described 
elsewhere [14]. 
Genotyping was conducted by pulsed-field gel 
electrophoresis (PFGE) with SmaI as previously 
described [15] to a randomly selected group of 17 
isolates. Comparison of the PFGE fingerprints was 
performed by the unweighted pair group method with 
arithmetic mean (UPGMA) clustering analysis, 
applying the Dice correlation coefficient [16]. 
 
Statistical analysis 
The variables and their modalities are shown in 
Table 1. 
Categorical data were compared by the Chi-square 
(2) test with Epi Info (TM) 3.5 software from CDC 
Atlanta US 
(http://wwwn.cdc.gov/epiinfo/html/downloads.htm). P 
values of <0.05 were considered statistically 
signiﬁcant. 
To identify the socio-demographic and clinical 
characteristics ofthe study population, factorial 
multiple correspondence analysis (FMCA) [17,18] was 
performed, followed by a cluster analysis [19,20]. The 
intervening variables were type of injury, age, sex, 
family partners with identical symptoms, nutritional 
status, infections, and anatomic location of the lesions; 
these were active variables. Illustrative variables were 
length of stay, no resistance to β-lactam antibiotics, 
and presence of PVL genes. 
Ward’s [21,22] method was used for the 
hierarchical classification into groups. Efficiency of 
the differences between inertia and stability of the 
group numbers in different classes was compared. 
FAMC and cluster analysis wasperformed using 
SPAD 4.0 software (Centre International de Statistique 
et d’Informatique Appliquées, CISIA-CERESTA 
1987-1999, Montreuil, France). 
Finally, associations between typologies and 
resistance profiles were examined. 
 
Results 
A total of 138 children with CA-MRSA SSTIs 
were enrolled. The median age was 3 years (range, 1 
month to 14 years), and 39.6% of children were 
younger than 2 years of age. Seventy-seven patients 
required hospitalization due to the severity of the 
infection.   
von Specht et al. –CA-MRSA skin and soft tissue pediatric infections        J Infect Dev Ctries 2014; 8(9):1119-1128. 
1121 
  Table 1.Factorial analysis of multiple correspondences. Variable and modality labels.  
Variable Categories  Category labels  
Age group   Infants: 0.1-1.9 years Infants 
Preschool 2-4 years Preschool  
Schoolchildren1: 5-8 years School1 
Schoolchildren2: 9-14 years School2 
Gender  Male Male 
Female  Female 
Nutritional status  Eutrophic Eutrophic 
Underweight Underweight 
Undernutrition grade 1 Undernutrition 1 
Undernutrition grade 2 Undernutrition 2 
Length of stay  Outpatient  LOS=0 
< 3 days LOS(1-<3) 
 3-4 days LOS (3-4) 
 5-6 days LOS (5-6) 
>6 days LOS (>6) 
 Family members with identical symptoms  None Cohab (0) 
One  Cohab (1) 
Two or more  Cohab (2+) 
Clinical presentation Impetigo  Impetigo  
Cellulitis Cellulitis 
Abscess Abscess 
Pyoderma Pyoderma 
Other: infected wound Other:inf wound 
Anatomical location  Arms   Arms 
Face/neck Face 
Scalp Scalp 
Generalized infection Generalized inf 
Groin, buttocks, or perineum Groin/buttocks/per 
Lower limbs  Lower limbs 
Trunk   Trunk 
Co-infections   Scabies Scabies 
Mycoses Mycoses  
No co infection No coinf 
Group A β-hemolytic streptococcus SBHGA 
Chickenpox  Chickenpox 
No data  Coin no data 
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  Table 2.CA-MRSA skin andsoft tissue infections.Characteristics of patients by inpatient or outpatient status. Provincial 
Pediatric Hospital of Misiones, 2003–2006. 
Characteristic Admitted 
N=77 (55.8%) 
Outpatient 
N=61 (44.2%) 
Total p 
Age group  Infants 37 (48%) 17 (27.8%) 54 0.01 
Preschool/Schoolchildren 40 (52%) 44 (72.2%) 84  
Gender  Male 38 (49.4%) 36 (59%) 74 0.25 
Female 39 (50.6%) 25 (41%) 64 
Nutritional status  Undernutrition 9 (11.7%)1 11(18.0%)1a 20 0.1 
Eutrophic 47 (61%) 27(44.3%) 74 
ND 21 (27.3%) 23(37.7%) 44 
Family members with identical 
symptoms 
None 14 (53.8%) 12(46.2%) 26 0.2 
One or more 26 (38.2%) 42(61.8 %) 68 
ND 37 (84%) 7(16%) 44 
Immediately prior antibiotic treatment Yes 27 (35.1%) 24(39.3%) 61 0.04 
No 26 (33.8%) 9(14.8%) 35 
ND 24 (31.2%) 28(45.9%) 52 
Six-month prior antibiotic treatment6 Yes 23 (29.8%) 18 (29.5%) 416 0.41 
No 36 (46.7%) 23 (37.7%) 59 
ND 18 (22.4%) 20 (32.8%) 38 
Anatomical location7 Scalp 3 (30%) 7(70%) 10 0.048 
Arms2 7 (46.7%) 8 (53.3%) 15 
Generalized infection3 12 (54.5%) 10 (45.5%) 22 
Face/neck 8 (47.1%) 9 (52.9%) 17 
Lower limbs 19 (73.1%) 7(26.9%) 26 
Trunk4 10 (52.6%) 9(47.4%) 19 
Groin, buttocks, or perineum 13 (86.7%) 2 (13.3%) 15 
ND 5 (35.7) 9 (64.3%) 14 
Clinical presentation Impetigo 8 (21.1%) 30 (78.9%) 38 0.001 
Cellulitis 16 (100%) 0 16 
Abscess 45 (643%) 25 (35.7%) 70 
Pyoderma 6 (66.7%) 3(33.3%) 9 
Infected wound 2 (40%) 3 (60%) 5 
1Underweight: three patients; undernutrition grade 1: four patients; undernutrition grade 2: two patients; 1aAll underweight patients; 2Arms and hands; 3Head, 
neck, trunk and extremities; 4Back and abdomen; 5Immediately prior antibiotic treatment: patients treated at the time of sampling; 6Amoxicillin (26 patients); 
cephalexin (13 patients); azitromicyn (2 patients); 7For the variables’ anatomical location and clinical presentation, row profiles were considered. 
 
 
 
 
 
Table 3.CA-MRSA skin and soft tissue infections.Relationship between the lengths of stay and the classes of patients. 
 Outpatients LOS(1–<3) LOS(3–<4) LOS(4–<6) LOS(6+) Total 
 N (%) N (%) N (%) N (%) N (%) N 
Class 1 3 (9.68) 6 (19.35) 8 (25.81) 9 (29.03) 5 (16.13) 31 
Class 2 9 (39.13) 2 (8.70) 6 (26.09) 2 (8.70) 4 (17.39) 23 
Class 3 16 (84.21) 1 (5.26) 1 (5.26 ) 0 1 (5.26) 19 
Class 4 10(47.62) 4 (19.05) 3 (14.29) 1 (4.76) 3 (14.29) 21 
Total 38 (40.43) 13 (13.83) 18 (19.15) 12 (12.77) 13 (13.83) 94 
LOS: length of stay in days 
p = 0.001 
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Among them, the median length of hospitalization 
was 4 days (range, 1 to 22 days). Although all patients 
survived, some of them had serious complications, 
including the need for hospitalization in the intensive 
care unit in two cases. 
Demographic and clinical characteristics of 
children and their distribution according to the need to 
be admitted to the hospital are shown in Table 2. 
Hospitalization was more common among younger 
children (infants) compared to the rest of the age 
groups (p < 0.05), while patients in the older age 
groups (preschool and school children) were more 
frequently treated as outpatients (p < 0.05) 
Out of 138 patients, 46% were female. A higher 
percentage of these patients required hospitalization 
(61%, p < 0.05) compared to male patients (54%). 
From the group of children in which nutritional status 
was evaluated (n = 94), 20 had some degree of 
malnutrition (21%), and hospitalization was required 
in 9 of them (45%). However 47/74 eutrophic patients 
were admitted (p = 0.1, Table2). None were receiving 
immunosuppressive therapy. 
In 51 of the 86 patients from whom data were 
obtained, immediately prior antibiotic treatment with 
first-generation cephalosporins was recorded. 
Data of antibiotic therapy for any infection in the 
previous six months were obtained for 100 patients; 41 
of them had received antibiotics (amoxicillin, 63% and 
cephalexin, 32%;Table 2). 
Regarding the infection source, 68/94 children had 
close contact with at least one relative with similar 
symptoms. The distribution of this variable among 
hospitalized patients or outpatients was not statistically 
significant (Table 2). 
The main clinical presentations were abscesses, 
followed by impetigo and cellulitis (Table 2). All 
cellulitis cases (16) and 64% of the abscesses required 
hospitalization. On the other hand, 78% of the 
impetigo cases were treatedas outpatients (p < 0.05). 
The majority of the infections were located on the 
lower limbs or spread across the head, neck, trunk, and 
extremities (Table 2). Most children with infections of 
the lower limbs (19/26) and buttocks, perineum,or 
groin (13/15) required hospitalization (p < 0.05). 
Concurrent Streptococcus pyogenes infections 
were observed in 17 patients with impetigo. Three of 
them required hospitalization. In terms of other skin 
conditions, five children had scabies, three had 
mycosis, and four had chickenpox in both groups 
(hospitalized or ambulatory). 
 
Antimicrobial susceptibility 
All the MRSA isolates (n = 138) were susceptible 
to trimethoprim/sulfamethoxazole and minocycline. 
Resistance to non -lactam antibiotics was low: 
erythromycin (11%), gentamicin (9%), rifampicin 
6.2%), ciprofloxacin (2.3%), clindamycin (2.3%), and 
chloramphenicol (2.2%). The main pattern (only 
resistant to β-lactam antibiotics) was present in 
111isolates (80%), followed by resistance to 
erythromycin (5%), rifampicin (4%), and 
gentamicin(3%). Other minor resistance patterns were 
also detected (8%). 
Resistance pattern distribution among age groups, 
clinical diagnosis, previous antibiotic treatment, or 
infection site was not statistically significant. 
 
Molecular characterization 
Molecular analysis was performed on a total of 44 
available isolates. Panton-Valentine leukocidin (PVL) 
geneswere detected in 30 (62%). Staphylococcal 
cassette chromosome mec (SCCmec) type IV was 
detected in 44/44 isolates. 
Six PFGE patterns were found; isolates with 
indistinguishable patterns were grouped in the same 
pulsotype and coded with capital letters (A–G). The 
two major groups were Type A (n = 7) and Type G (n 
= 4). PVL genes were carried by 6/7 isolates of 
pulsotypeA, 4/5 of pulsotype G, and 3/3 of pulsotype 
B. Pulsotypes C, E, and F were PVL (-), with one 
isolate each. 
 
Patients’ characteristics 
Although a total of 138 isolates and patients were 
initially considered, the 94 with complete clinical or 
epidemiological data were used to perform the FAMC. 
Overall inertia (variance) of the data matrix in 
these FACM was 3.29. The first three factors 
accounted for 26% of the total variance. Factor 1 (F1) 
and factor 2 (F2) are displayed in the main plane. For 
more clarity to show labels, the same figure is shown 
in three parts (Figures 1A, B, C). 
The following factors contributed to factor 1 on 
the positive side: impetigo, patients without affected 
cohabiting family members, low weight, lesion in face, 
and injuries with co-infection by Streptococcus 
pyogenes (SBHGA). On the negative side, factors 
included cellulitis, malnutrition, and injuries located in 
lower limbs (Figure 1A). 
Factors contributing to form the positive side of 
factor 2 were younger age, scabies, chickenpox, and 
injuries in groin, buttocks, or perineum. On the 
negative side, factors included two cohabitants, cases 
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with no data about co-infection and lesions in the 
trunk. 
Illustrative variables can be seen projected on the 
main plane (Figure 1B). F1 displays the opposition of 
the children requiring hospitalization on the left side of 
the origin, to those that could be treated as outpatients 
on the positive side, near RA 2+. No resistance 
patterns (RA0) are projected in the origin, near PVL 
NR. 
In the main plane, right area, medical conditions 
requiring more complex treatments are projected close 
to (related to) the first of these groups. In this regard, 
cellulitis and abscesses correspond with patients 
requiring hospitalization, and with patients who had 
abscesses in their legs, groin, buttocks, perineum, and 
trunk. 
As an infection of lesser compromise, not 
requiring hospitalization, impetigo (related to low 
weight and no family members with identical 
symptoms) is projected to the right side of the origin. 
Age groups are separated along the second axis. A 
relationship was found between the youngest age 
(infant) and widespread skin lesions, in which 
treatment could be performed without requiring 
hospitalization. 
The dendrogram and hierarchic classification 
resulted in four distinctive classes of patients (Figure 
1C). 
Class 1 included children requiring hospitalization 
with cellulitis, having cohabiting family members with 
symptoms, and having infections localized in legs, 
groin, buttocks, and perineum (n = 31). 
Class 2 included children with two or more 
cohabitants with similar symptoms, and children with 
infections localized in the trunk and arms(n = 23). 
Class 3 included patients treated as low-weight 
outpatients diagnosed with primary impetigo, patients 
co-infected with β-hemolytic Streptococcus, and 
patients with infections localized in head and neck 
who had no affected cohabiting family members (n = 
19). 
Class 4 included children with pyoderma, 
generalized infection, and chickenpox (n = 21). 
This typology was considered a new variable. 
Differences in the length of hospital stay distribution 
among the classes were statistically significant (p < 
0.05), as patients in class 1 required longer hospital 
stays compared to all the other classes (Table3). 
Although a limited number of isolates were 
genotyped, no significant statistical association could 
be observed between detection of the PVL coding 
genes and the classes defined in this study. The same 
lack of significance was observed concerning the 
distribution of resistance to non-β-lactam antibiotics. 
 
Discussion 
CA-MRSA is recognized to cause a variety of 
infections in previously healthy children [1,23-29]. 
Purulent SSTIs caused by CA-MRSA are the most 
frequent clinical manifestations [2,30]. 
Over the past decade, CA-MRSA infection has 
become a quickly growing problem in pediatric 
hospitals [29,31]. As there is no definite consensus 
about why otherwise healthy children acquire these 
resistant bacteria, we decided to evaluate the clinical 
and microbiological characteristics of CA-MRSA 
isolates recovered from 138 consecutive patients with 
SSTIs. Considering that many patients suffering from 
SSTIs are not microbiologically diagnosed, our results 
represent only a fraction of these infections treated at 
the hospital. 
Figure 1.CA-MRSA Skin and soft tissue infections. First 
factorial biplot. Illustrative variable: Length of Stay. Provincial 
Pediatric Hospital, 2003-2006. References; ■active variables, 
▲illustrative variables. 
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In our study, the largest age group included 
patients up to two years of age (54 children), although 
no statistically significant differences were observed 
with respect to the other age groups. This finding is in 
agreement with other studies, in which the median age 
is similar to our series [32-34], that concluded that age 
was not a significant predictor for MRSA skin and soft 
tissue infections [30]. However, others noted a higher 
incidence of MRSA among children younger than two 
years of age [34]. 
The admission requirement observed in this study 
(56%) is markedly higher than that reported by other 
researchers. Inadult patients with SSTIs due to CA-
MRSA, the reported frequency is variable, ranging 
from 16% to 44% [2]. In children, Lee et al. found that 
only 4% of patients required hospitalization for further 
treatment [35]. Such observed variations could reflect 
some clinical determinants, such as depth and/or 
extent of lesions [34] as well as treatment failures or a 
very young age [30]. 
While we found that a greater number of patients 
under two years of age were admitted (Table 2), 
similar to what other authors found [30], we observed 
that the number of hospitalizations could be higher for 
extrinsic reasons to the infectious process (e.g., 
derivation from remote health centers, families with 
little potential for monitoring, etc.); these patients, in 
an urban setting near the hospital, might have been 
treated as outpatients. The predominance of male 
gender among patients suffering from MRSA 
infections has been documented, particularly among 
invasive infections by CA-MRSA, but not among 
SSTIs [34,36-38]. However, results obtained by Chen 
et al. indicated that gender could not be considered a 
SSTI MRSA predictor [30]. In our work, both genders 
were almost equally represented (Table 2). 
The fact that most of the children were receiving 
antibiotic treatment with first-generation 
cephalosporins, inappropriate for MRSA, shows the 
lack of knowledge of the treating physicians at the 
time about MRSA emergence in the community. 
Several studies suggested that frequent exposure to 
antimicrobial agents can facilitate the acquisition of 
MRSA [39-41], especially multiple antibiotics 
treatments in the previous year [42], which was also 
concluded in a meta-analysis conducted in 2008 [43]. 
However, other studies arrived at the opposite 
conclusion, that there was no difference between the 
acquisition of MRSA and non-MRSA [34,44,45]. Data 
about antibiotic therapy in the previous six months 
showed the frequent use of -lactam antibiotics, which 
may have contributed to the selection of CA-MRSA. 
Direct contact with infected patients or colonized 
subjects is implicated in the transmission of CA-
MRSA infection, and intrafamily spread of CA-MRSA 
is frequent and most certainly accounts for an 
increasing number of cases [2]. In this study, most 
patients reported family members with identical 
symptoms (Table 2). 
Abscesses and cellulitis have been described as the 
most common CA-MRSA skin and soft tissue 
infections [2, 36]. Similarly, subcutaneous abscesses 
were the most frequent diagnoses in our series, 
particularly those located in lower limbs, as also 
described by other authors [2,30,44,46]. 
The associated resistance to erythromycin (11%) is 
similar to other patient series [29,34,47], but is 
significantly lower than those reported by other 
authors [30,33]. 
Several antibiotics, including clindamycin and 
trimethoprim-sulfamethoxazole, have been proposed 
for the treatment of suspected CA-MRSA skin 
infections in outpatient settings [48-50]. In this study, 
resistance to clindamycin was lower than that 
described by other Argentine authors [44]; this could 
be due to a decrease in the use of this drug by that 
time, and also to differences in the population under 
study. However, our rate of resistance was similar to 
those reported in other countries (3%) [30]. All strains 
were sensitive to trimethoprim/sulfamethoxazole, so 
these antibiotics could be considered first-line options 
for empirical treatment at our center. 
In the present study, the MRSA isolates that were 
molecularly evaluated (44) were found to exhibit 
typical phenotypic molecular features associated with 
community-acquired MRSA [51], including resistance 
profile, the presence of SCCmec IV in 100% of 
isolates, and the presence of PVL coding genes in the 
majority of the isolates. Our data have practical value 
in the assessment of predisposing factors, and 
represent a contribution to the optimal management of 
S. aureus SSTI. Patients with greater compromise 
were grouped in class 1, whose infections were the 
most invasive of the series and required more effort 
and length of treatment; most of these infections were 
located in the legs, groin, buttocks, and perineum 
(Table 3). Similar relationships were observed by 
other authors [52,53]. 
The other classes were consistent, and included 
patients with lower clinical compromise. Thus, the 
class 2 patients (infections on the trunk and arms with 
two or more cohabiting family members with similar 
symptoms) could probably be treated as outpatients. In 
this situation, the physician could also consider 
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studying and eventually treating the household 
members who had similar symptoms. 
In contrast, for those patients grouped in class 3, it 
is important to consider the possible therapeutic failure 
in the choice of TMS for empirical therapy due to 
Streptococcuspyogenesco-infection [54]. 
Finally, class 4 included patients with superficial 
widespread infections, the lowest clinical compromise 
that represents the wide range of skin and soft tissue 
infections caused by CA-MRSA, as described by 
several authors [55,56]. 
Limitations of this study include: missing data for 
some variables, which led us to define the category as 
unknown; a limited number of isolates available for 
molecular studies; and our retrospective design, which 
makes our results predisposed to potential biases of 
studies of similar design. 
 
Conclusions 
Despite the limitations described, this study 
increases our understanding and knowledge about CA-
MRSA skin and soft tissue infections in pediatric 
patients. Further studies on the role of antibiotics in 
treating CA-MRSA cutaneous infections and 
surveillance for more invasive infections are needed. 
Surveillance is considered to be the main resource to 
achieve information and implement actions. 
Continuous efforts should be made to control this 
significant public health problem. 
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